ControlRad
PrivateLast Round
Debt
Mar 29, 2022
Total Funding Raised
$28.3M
Company Overview
ControlRad operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Debt round in March 2022.
ControlRad, Inc. is a privately held medical technology company that develops and markets innovative products designed to dramatically reduce radiation exposure for patients and healthcare professionals during fluoroscopically guided procedures (FGP). The company's technology, which includes products like ControlRad Select and ControlRad Trace, can be retrofitted onto existing C-arm imaging systems from major manufacturers. These products use a proprietary system of semi-transparent filters, a tablet interface, and image processing algorithms to optimize the X-ray beam, delivering high-quality images in the region of interest while reducing peripheral radiation by up to 89%. The company has received multiple FDA 510(k) clearances for its products and has entered into commercial agreements, including an exclusive distribution deal with Boston Scientific for its ControlRad Select technology. Founded in 2011, ControlRad is headquartered in the Atlanta, Georgia area with research and development facilities in Israel.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ControlRad Comparables
Compare ControlRad with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Radiaction Medical | 85% | |
| IKOMED Technologies | 84% | |
| Omega Medical Imaging | 83% |
For institutional investors. Book with your work email.
ControlRad Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 29, 2022 | ||||
| Series C | Sep 11, 2020 | ||||
| Series B | Sep 18, 2019 | ||||
| VC Round | Jul 25, 2017 | ||||
| VC Round | Jul 12, 2016 | ||||
VC Round | Feb 27, 2015 |
For institutional investors. Book with your work email.
ControlRad Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Questa Capital | Series B, Series C |
| Rapha Capital Management | VC Round, Series B |
| Windham Capital Partners | Series C |
ControlRad Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ControlRad's valuation, stock price, and market status.
Is ControlRad a public or private company?
ControlRad is a private company.
What is the current stock price of ControlRad?
ControlRad is a private company, so its shares have no public market price. Caplight tracks ControlRad's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ControlRad worth (valuation)?
Valuation information for ControlRad is not publicly available.
Can I buy ControlRad stock?
ControlRad shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ControlRad's last funding round?
ControlRad's most recent funding round was Debt on March 29, 2022.
Who are the main investors in ControlRad?
Key investors in ControlRad include Questa Capital.
Will ControlRad IPO soon?
No public IPO plans have been announced for ControlRad.
How can I track ControlRad secondary market activity?
Caplight tracks bids, offers, and trades in ControlRad's shares on secondary markets.